Switch theme
Sign up to access all valuation multiples
Great Tree Pharmacy Co Ltd is engaged in the management and trade of various drugs, health products, goods for mothers and babies, and cosmetics products. The firm also provides coordinated medicine procurement services to various clinics, outpatient centers, and medical communities. Besides, the company is also an agency for domestic and foreign healthcare products sold in clinics, outpatient centers, and medical communities.
2001
2.3K+
LTM Revenue $606M
LTM EBITDA $54.1M
$839M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Great Tree Pharmacy has a last 12-month revenue (LTM) of $606M and a last 12-month EBITDA of $54.1M.
In the most recent fiscal year, Great Tree Pharmacy achieved revenue of $576M and an EBITDA of $56.9M.
Great Tree Pharmacy expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Great Tree Pharmacy valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $606M | XXX | $576M | XXX | XXX | XXX |
| Gross Profit | $174M | XXX | $162M | XXX | XXX | XXX |
| Gross Margin | 29% | XXX | 28% | XXX | XXX | XXX |
| EBITDA | $54.1M | XXX | $56.9M | XXX | XXX | XXX |
| EBITDA Margin | 9% | XXX | 10% | XXX | XXX | XXX |
| EBIT | $28.3M | XXX | $26.7M | XXX | XXX | XXX |
| EBIT Margin | 5% | XXX | 5% | XXX | XXX | XXX |
| Net Profit | $23.5M | XXX | $22.7M | XXX | XXX | XXX |
| Net Margin | 4% | XXX | 4% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Great Tree Pharmacy's stock price is TWD 159 (or $5).
Great Tree Pharmacy has current market cap of TWD 21.0B (or $701M), and EV of TWD 25.2B (or $839M).
See Great Tree Pharmacy trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $839M | $701M | XXX | XXX | XXX | XXX | $0.18 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Great Tree Pharmacy has market cap of $701M and EV of $839M.
Great Tree Pharmacy's trades at 1.5x EV/Revenue multiple, and 14.7x EV/EBITDA.
Equity research analysts estimate Great Tree Pharmacy's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Great Tree Pharmacy has a P/E ratio of 29.8x.
See valuation multiples for Great Tree Pharmacy and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $701M | XXX | $701M | XXX | XXX | XXX |
| EV (current) | $839M | XXX | $839M | XXX | XXX | XXX |
| EV/Revenue | 1.4x | XXX | 1.5x | XXX | XXX | XXX |
| EV/EBITDA | 15.5x | XXX | 14.7x | XXX | XXX | XXX |
| EV/EBIT | 29.6x | XXX | 31.4x | XXX | XXX | XXX |
| EV/Gross Profit | 4.8x | XXX | n/a | XXX | XXX | XXX |
| P/E | 29.8x | XXX | 30.9x | XXX | XXX | XXX |
| EV/FCF | 34.8x | XXX | 33.7x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialGreat Tree Pharmacy's last 12 month revenue growth is 12%
Great Tree Pharmacy's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.1M for the same period.
Great Tree Pharmacy's rule of 40 is 22% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Great Tree Pharmacy's rule of X is 38% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Great Tree Pharmacy and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 12% | XXX | 12% | XXX | XXX | XXX |
| EBITDA Margin | 9% | XXX | 10% | XXX | XXX | XXX |
| EBITDA Growth | 9% | XXX | 3% | XXX | XXX | XXX |
| Rule of 40 | 22% | XXX | 22% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 38% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.3M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 20% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 23% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| MedPlus India | XXX | XXX | XXX | XXX | XXX | XXX |
| SC Ropharma | XXX | XXX | XXX | XXX | XXX | XXX |
| Pague Menos | XXX | XXX | XXX | XXX | XXX | XXX |
| Droga Raia | XXX | XXX | XXX | XXX | XXX | XXX |
| Redcare Pharmacy | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Great Tree Pharmacy acquired XXX companies to date.
Last acquisition by Great Tree Pharmacy was XXXXXXXX, XXXXX XXXXX XXXXXX . Great Tree Pharmacy acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Great Tree Pharmacy founded? | Great Tree Pharmacy was founded in 2001. |
| Where is Great Tree Pharmacy headquartered? | Great Tree Pharmacy is headquartered in Taiwan. |
| How many employees does Great Tree Pharmacy have? | As of today, Great Tree Pharmacy has 2.3K+ employees. |
| Is Great Tree Pharmacy publicy listed? | Yes, Great Tree Pharmacy is a public company listed on ROCO. |
| What is the stock symbol of Great Tree Pharmacy? | Great Tree Pharmacy trades under 6469 ticker. |
| When did Great Tree Pharmacy go public? | Great Tree Pharmacy went public in 2014. |
| Who are competitors of Great Tree Pharmacy? | Similar companies to Great Tree Pharmacy include e.g. MedPlus India, SC Ropharma, Pague Menos, Droga Raia. |
| What is the current market cap of Great Tree Pharmacy? | Great Tree Pharmacy's current market cap is $701M |
| What is the current revenue of Great Tree Pharmacy? | Great Tree Pharmacy's last 12 months revenue is $606M. |
| What is the current revenue growth of Great Tree Pharmacy? | Great Tree Pharmacy revenue growth (NTM/LTM) is 12%. |
| What is the current EV/Revenue multiple of Great Tree Pharmacy? | Current revenue multiple of Great Tree Pharmacy is 1.4x. |
| Is Great Tree Pharmacy profitable? | Yes, Great Tree Pharmacy is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Great Tree Pharmacy? | Great Tree Pharmacy's last 12 months EBITDA is $54.1M. |
| What is Great Tree Pharmacy's EBITDA margin? | Great Tree Pharmacy's last 12 months EBITDA margin is 9%. |
| What is the current EV/EBITDA multiple of Great Tree Pharmacy? | Current EBITDA multiple of Great Tree Pharmacy is 15.5x. |
| What is the current FCF of Great Tree Pharmacy? | Great Tree Pharmacy's last 12 months FCF is $24.1M. |
| What is Great Tree Pharmacy's FCF margin? | Great Tree Pharmacy's last 12 months FCF margin is 4%. |
| What is the current EV/FCF multiple of Great Tree Pharmacy? | Current FCF multiple of Great Tree Pharmacy is 34.8x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
